MELISSA DUKE: Open Payments
NPI 1225437155 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 18 payments from 7 companies in 2025. Trend: 2023 $831 · 2024 $477 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $223 |
| PFIZER INC. | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Boston Scientific Corporation | 1 | $19 |
Products named: CARDIOMEMS, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, VYNDAQEL, LifeVest, CAMZYOS, VERQUVO, RESONATE EL ICD VR, WAINUA.
Industry payments across OK — which companies pay providers there.
